Novartis reaches agreement to buy Texas-based Encore Vision

(Reuters) - Swiss drug maker Novartis AG said on Tuesday it had reached a definitive agreement to acquire Fort Worth, Texas-based Encore Vision, which is focused on developing a novel treatment in presbyopia, or far-sightedness.